Allarity launches effort to combat potential illegal naked short selling

Allarity (ALLR) Therapeutics has engaged Shareholder Intelligence Services to investigate potential illegal naked short selling and other potential trading irregularities by third parties in the Company’s common stock. The engagement with ShareIntel is part of Allarity’s commitment to protecting shareholder value and ensuring fair and transparent trading of its stock. ShareIntel utilizes its proprietary DRIL-Down technology, a compliance-driven data analytics platform, to track and analyze stock trading activity from broker-dealers, clearing firms, and reporting entities. Through this agreement, Allarity will monitor potential trading abuses, detect unusual short-selling patterns, and investigate possible market manipulation, taking corrective action, including legal recourse if necessary. The Company will leverage ShareIntel’s market surveillance tools to detect potential violations of the U.S. Securities and Exchange Commission’s Regulation SHO, which governs short-selling practices, stock borrowing requirements, and fail-to-deliver obligations. If evidence of market manipulation or illegal short selling is uncovered, Allarity will consider all available options to hold responsible parties accountable.